Literature DB >> 11230392

Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.

N A Cunliffe1, J S Gondwe, S M Graham, B D Thindwa, W Dove, R L Broadhead, M E Molyneux, C A Hart.   

Abstract

In a 2-year study of viral gastroenteritis in children in Blantyre, Malawi, the diversity of rotavirus strains was investigated by using electropherotyping, reverse transcription-PCR amplification of the VP7 and VP4 genes (G and P genotyping), and nucleotide sequencing. Of 414 rotavirus strains characterized, the following strain types were identified: P[8], G1 (n = 111; 26.8%); P[6], G8 (n = 110; 26.6%); P[8], G3 (n = 93; 22.5%); P[4], G8 (n = 31; 7.5%); P[8], G4 (n = 21; 5.1%); P[6], G3 (n = 12; 2.9%); P[6], G1 (n = 7; 1.7%); P[6], G9 (n = 3; 0.7%); P[6], G4 (n = 3; 0.7%); P[4], G3 (n = 1; 0.2%); and mixed (n = 15; 3.6%). While all strains could be assigned a G type, seven strains (1.7%) remained P nontypeable. The majority of serotype G8 strains and all serotype G9 strains had short electropherotype profiles. All remaining typeable strains had long electropherotypes. Divergent serotype G1 rotaviruses, which contained multiple base substitutions in the 9T-1 primer binding site, were commonly identified in the second year of surveillance. Serotype G2 was not identified. Overall, G8 was the most frequently identified VP7 serotype (n = 144; 34.8%) and P[8] was the most frequently detected VP4 genotype (n = 227; 54.8%). Partial sequence analysis of the VP4 gene of genotype P[8] rotaviruses identified three distinct clusters, which predominantly (but not exclusively) comprised strains belonging to a distinct VP7 serotype (G1, G3, or G4). As a result of mutations in the 1T-1 primer binding site, strains belonging to each cluster required a separate primer for efficient typing. One cluster, represented by P[8], G4 strain OP354, was highly divergent from the established Wa and F45 VP4 P[8] lineages. As is the case for some other countries, the diversity of rotaviruses in Malawi implies that rotavirus vaccines in development will need to protect against a wider panel of serotypes than originally envisioned.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230392      PMCID: PMC87838          DOI: 10.1128/JCM.39.3.836-843.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  58 in total

Review 1.  Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization.

Authors:  N A Cunliffe; P E Kilgore; J S Bresee; A D Steele; N Luo; C A Hart; R I Glass
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

2.  Detection and characterization of novel rotavirus strains in the United States.

Authors:  M Ramachandran; J R Gentsch; U D Parashar; S Jin; P A Woods; J L Holmes; C D Kirkwood; R F Bishop; H B Greenberg; S Urasawa; G Gerna; B S Coulson; K Taniguchi; J S Bresee; R I Glass
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

4.  Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3' end of the primer binding site.

Authors:  M I Adah; A Rohwedder; O D Olaleyle; H Werchau
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

5.  Characterization of VP6 subgroup, VP7 and VP4 genotype of rotavirus strains in Lusaka, Zambia.

Authors:  A D Steele; F C Kasolo; P Bos; I Peenze; H Oshitani; E Mpabalwani
Journal:  Ann Trop Paediatr       Date:  1998-06

6.  Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.

Authors:  M Santosham; L H Moulton; R Reid; J Croll; R Weatherholt; R Ward; J Forro; E Zito; M Mack; G Brenneman; B L Davidson
Journal:  J Pediatr       Date:  1997-10       Impact factor: 4.406

7.  Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains.

Authors:  N A Cunliffe; J S Gondwe; R L Broadhead; M E Molyneux; P A Woods; J S Bresee; R I Glass; J R Gentsch; C A Hart
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

8.  Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis.

Authors:  J P Leite; A A Alfieri; P A Woods; R I Glass; J R Gentsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Further characterization of field strains of rotavirus from Nigeria VP4 genotype P6 most frequently identified among symptomatically infected children.

Authors:  M I Adah; A Rohwedder; O D Olaleye; O A Durojaiye; H Werchau
Journal:  J Trop Pediatr       Date:  1997-10       Impact factor: 1.165

10.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.

Authors:  J Joensuu; E Koskenniemi; X L Pang; T Vesikari
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

View more
  51 in total

1.  Detection and characterization of rotaviruses in hospitalized neonates in Blantyre, Malawi.

Authors:  N A Cunliffe; S Rogerson; W Dove; B D M Thindwa; J Greensill; C D Kirkwood; R L Broadhead; C A Hart
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Application of restriction fragment length polymorphism analysis of VP7-encoding genes: fine comparison of Irish and global rotavirus isolates.

Authors:  F O'Halloran; M Lynch; B Cryan; S Fanning
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent.

Authors:  N A Page; A D Steele
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in Hungary.

Authors:  Krisztián Bányai; Jon R Gentsch; Roger I Glass; Mária Uj; Ilona Mihály; György Szücs
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

5.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Genetic variability among serotype G4 Italian human rotaviruses.

Authors:  S Arista; G M Giammanco; S De Grazia; C Colomba; V Martella
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.

Authors:  Serenella Arista; Giovanni M Giammanco; Simona De Grazia; Stefania Ramirez; Concetta Lo Biundo; Claudia Colomba; Antonio Cascio; Vito Martella
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

8.  Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.

Authors:  Jennifer J Hull; Nigel Cunliffe; Khuzwayo C Jere; Sung-Sil Moon; Yuhuan Wang; Umesh Parashar; Baoming Jiang
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

9.  Characterization of rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P[8] strains.

Authors:  T K Fischer; J Eugen-Olsen; A G Pedersen; K Mølbak; B Böttiger; K Rostgaard; N M Nielsen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Genetic characterization of a novel, naturally occurring recombinant human G6P[6] rotavirus.

Authors:  Mustafizur Rahman; Karolien De Leener; Truus Goegebuer; Elke Wollants; Ingrid Van der Donck; Lieve Van Hoovels; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.